New York, NYNCT07335497Now EnrollingIRB Ready

Locally Advanced / Metastatic Solid Tumors Clinical Trial in New York, NY

Access cutting-edge locally advanced / metastatic solid tumors treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Crescent Biopharma, Inc.

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access locally advanced / metastatic solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related locally advanced / metastatic solid tumors treatment provided free

Apply for This New York Location

Check if you qualify for this locally advanced / metastatic solid tumors clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Locally Advanced / Metastatic Solid Tumors Study in New York

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.

Sponsor: Crescent Biopharma, Inc.

Who Can Participate

Inclusion Criteria

Life expectancy ≥ 3 months
Eastern Cooperative Oncology Group (ECOG) performance status score of 0 - 1
Adequate organ function and hematologic reserve based on laboratory parameters
Have measurable disease defined by RECIST v1.1
For Backfill and Dose Optimization: Willingness to provide recent archival tumor tissue sample or willingness to undergo biopsy
Tumor Indication specific inclusion criteria:
For dose escalation or backfill: progressing from, intolerant to, or ineligible for (due to unavailability or contraindication) local standard of care therapies and have one of the following locally advanced or metastatic tumor types:
Hepatocellular carcinoma
Biliary tract cancer
Endometrial carcinoma
Cervical cancer
Ovarian cancer
Gastric or gastroesophageal cancer
Colorectal cancer
Non-small cell lung cancer Key

Exclusion Criteria

Has malignancies other than disease under study within the past 3 years
Has conditions requiring treatment with clinically significant or increasing doses of systemic steroid therapy
Has not adequately recovered from recent major surgery
Has ongoing clinically significant toxicity related to prior therapy
Has active central nervous system (CNS) metastases
Has active autoimmune disease requiring systemic therapy in the past 2 years (replacement therapy is permitted)
Has a history of serious Grade ≥ 3 immune-related adverse event (irAE)
Has a history of noninfectious pneumonitis/interstitial lung disease
Has an active severe infection
Has received a live or attenuated vaccine within 30 days of the first dose
Has undergone prior allogeneic stem cell or solid organ transplantation
Has protocol-specified events related to gastrointestinal perforation, surgery, wound healing complications, and bleeding
Has clinically significant cardiovascular disease NOTE: Other protocol defined Inclusion and Exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07335497) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Locally Advanced / Metastatic Solid Tumors Treatment Options in New York, NY

If you're searching for locally advanced / metastatic solid tumors treatment options in New York, NY, this clinical trial (NCT07335497) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced locally advanced / metastatic solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all locally advanced / metastatic solid tumors clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in New York, NY

See all leukemia clinical trials recruiting in New York — not just this study.

Browse Leukemia Trials in New York →

Browse More Trials by Condition

Leukemia TrialsAdvanced Solid Tumors TrialsAlzheimers Disease TrialsEssential Tremor TrialsAnkylosing Spondylitis TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY